Skip to main content
Clinical Trials/NCT01895023
NCT01895023
Completed
Phase 4

Dexmedetomidine Versus Midazolam Premedication on Emergence Agitation After Strabismus Surgery in Children

Yao Yusheng1 site in 1 country156 target enrollmentSeptember 2013

Overview

Phase
Phase 4
Intervention
Dexmedetomidine
Conditions
Inhalational Anesthetics Adverse Reaction
Sponsor
Yao Yusheng
Enrollment
156
Locations
1
Primary Endpoint
Emergence agitation
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Sevoflurane is frequently used for pediatric anesthesia because it has low pungency and rapid onset and offset of action.The reported incidence of emergence agitation (EA) following sevoflurane anesthesia varies from 10-80%. Despite its spontaneous resolution, EA is still considered as a potentially serious complication because of the risks of self-injury, and because of the stress caused to both caregivers and families.

Dexmedetomidine, an Alpha2-adrenoceptor agonist with sedative, analgesic, and anxiolytic actions, has been used in pediatric populations.Several prospective clinical trials in children have shown that dexmedetomidine significantly reduces the incidence of EA prior to recovery from sevoflurane anesthesia. However, the effect of dexmedetomidine premedication on emergence agitation has not been fully evaluated. The purpose of the present study was to verify the hypothesis that intranasal premedication with dexmedetomidine is effective in reducing emergence agitation after sevoflurane anaesthesia.

Detailed Description

Emergence agitation was assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale.The PAED scale contains five items (eye contact, purposefulness of actions,awareness of surroundings, restlessness and consolability), each scored on a 0 to 4 scale, for a maximum of 20 points. A perfectly calm child scores 0 and extreme agitation corresponds to 20 points. The peak EA score was recorded. Agitation scores \< 10 were interpreted as an absence of agitation, scores\>= 10 were regarded as presence of agitation.

Registry
clinicaltrials.gov
Start Date
September 2013
End Date
August 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Yao Yusheng
Responsible Party
Sponsor Investigator
Principal Investigator

Yao Yusheng

Dr.

Fujian Provincial Hospital

Eligibility Criteria

Inclusion Criteria

  • aged2-6 yr, with American Society of Anesthesiologists physical status I or II, scheduled to undergo strabismus surgery during general anesthesia

Exclusion Criteria

  • mental disease, neurologic disease, treatment with sedatives, full stomach, or indication for rapid sequence induction.

Arms & Interventions

Dexmedetomidine group

The dexmedetomidine group received intranasal dexmedetomidine 2mcg/kg premedication 45 min and oral saline 30 min before induction of anaesthesia

Intervention: Dexmedetomidine

Midazolam group

The midazolam group received intranasal saline 45 min and oral midazolam 0.5 mg/kg 30 min before induction of anaesthesia.

Intervention: Midazolam

Placebo Group

The Placebo group received intranasal saline premedication 45 min and oral saline 30 min before induction of anaesthesia

Intervention: Saline

Outcomes

Primary Outcomes

Emergence agitation

Time Frame: participants will be followed for the duration of PACU stay, an expected average of 1 hour

Emergence agitation was assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale.The PEAD scale contains five items (eye contact, purposefulness of actions,awareness of surroundings, restlessness and consolability), each scored on a 0 to 4 scale, for a maximum of 20 points. A perfectly calm child scores 0 and extreme agitation corresponds to 20 points. The peak EA score was recorded. scores\>= 10 were regarded as presence of agitation.

Secondary Outcomes

  • Postoperative vomiting(up to 24 hours)

Study Sites (1)

Loading locations...

Similar Trials